CAS 143945-39-5

2-Butyl-6-(1-methoxy-1-methylethyl)-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]quinazolin-4(3H)-one

Description:

2-Butyl-6-(1-methoxy-1-methylethyl)-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]quinazolin-4(3H)-one, with CAS number 143945-39-5, is a synthetic organic compound characterized by its complex molecular structure, which includes a quinazolinone core, a butyl side chain, and a biphenyl moiety substituted with a tetrazole group. This compound exhibits properties typical of quinazolinones, such as potential biological activity, which may include anti-inflammatory or anticancer effects, although specific biological data would depend on empirical studies. The presence of the tetrazole ring may enhance its pharmacological profile, contributing to its solubility and interaction with biological targets. The methoxy and methylethyl substituents can influence its lipophilicity and overall reactivity. As with many synthetic compounds, its stability, solubility, and reactivity can vary based on environmental conditions and the presence of other chemical species. Further research would be necessary to fully elucidate its properties and potential applications in medicinal chemistry or other fields.

Formula: C₃₀H₃₂N₆O₂

Synonyms:

• CL-329167
• 4(3H)-Quinazolinone, 2-butyl-6-(1-methoxy-1-methylethyl)-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
• CL329167

CL-329167

CAS: 143945-39-5

CL-329167, a angiotensin type 1 receptor antagonist, is used potentially for the treatment of hypertension.

Formula: C₃₀H₃₂N₆O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 508.61

Ref: TM-T27037